A Case Report on Antiphospholipid Antibody Syndrome with Chronic Pulmonary Embolism Secondary to Deep Vein Thrombosis and Thrombocytopenia

Case report

Authors

  • Naveena Gorrepati Pharmacist, Lifecare pharmacy , Sanantonio, Texas Author
  • Sambasiva Rao Tummala Manager, Regulatory Affairs, Stira Pharmaceuticals, Hyderabad, Telangana, India Author

Keywords:

Antiphospholipid antibody syndrome, Deep Vein Thrombosis, Thrombocytopenia, Hepati hemangioma, Pulmonary thrombi

Abstract

Antiphospholipid antibody syndrome (APS) is a multisystemic autoimmune disorder characterized by the persistent presence of antiphospholipid antibodies and a high risk of thrombotic events and adverse pregnancy outcomes. We report a case of a 42-year-old female patient with APS who developed chronic pulmonary embolism secondary to deep vein thrombosis (DVT) and thrombocytopenia. The patient presented with shortness of breath, cough with expectoration, black stools, and a history of DVT, abortion, and decreased platelet count. Physical examination revealed pallor, edema, and blackish discoloration of the right lower limb. Laboratory investigations showed anemia, thrombocytopenia, and an elevated reticulocyte count. Imaging studies, including ultrasonography and computed tomography (CT) scan, confirmed the presence of hepatic hemangioma and multiple pulmonary thrombi. The patient was diagnosed with APS with chronic pulmonary embolism secondary to DVT and thrombocytopenia. Treatment included anticoagulants (rivaroxaban and aspirin), diuretics (furosemide), antacids (pantoprazole), and symptomatic relief (cough syrup). This case highlights the importance of early recognition and prompt management of APS to prevent life-threatening thrombotic complications and adverse pregnancy outcomes

Downloads

Download data is not yet available.

Downloads

Published

30-04-2024

Issue

Section

Articles

How to Cite

A Case Report on Antiphospholipid Antibody Syndrome with Chronic Pulmonary Embolism Secondary to Deep Vein Thrombosis and Thrombocytopenia: Case report. (2024). Journal of Pharma Insights and Research, 2(2), 272–274. https://jopir.in/index.php/journals/article/view/154